Gilead and Roche sue Natco over generic Tamiflu
This article was originally published in Scrip
Executive Summary
Shares of Natco Pharma were down marginally on Indian bourses as Gilead Sciences and Roche filed an infringement suit against it in a US court concerning a generic version of Gilead's influenza treatment Tamiflu (oseltamivir phosphate) capsules.